Similar articles for PMID: 24868377

Year	Number of Results
2005	1
2006	2
2007	5
2008	4
2009	10
2010	7
2011	9
2012	13
2013	3
2014	17
2015	6
2016	7
2017	7
2018	3
2019	5
2020	7
2021	8
2022	10
2023	5
2024	0

1

Leucine-rich repeat kinase 2-linked Parkinson's disease: clinical and molecular findings.

Kumari U, Tan EK. Kumari U, et al. J Mov Disord. 2010 Oct;3(2):25-31. doi: 10.14802/jmd.10008. Epub 2010 Oct 30. J Mov Disord. 2010. PMID: 24868377 Free PMC article. Review.

2

Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.

Monfrini E, Di Fonzo A. Monfrini E, et al. Adv Neurobiol. 2017;14:3-30. doi: 10.1007/978-3-319-49969-7_1. Adv Neurobiol. 2017. PMID: 28353276 Review.

3

The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation.

Rudenko IN, Kaganovich A, Hauser DN, Beylina A, Chia R, Ding J, Maric D, Jaffe H, Cookson MR. Rudenko IN, et al. Biochem J. 2012 Aug 15;446(1):99-111. doi: 10.1042/BJ20120637. Biochem J. 2012. PMID: 22612223 Free PMC article.

4

G2385R and I2020T Mutations Increase LRRK2 GTPase Activity.

Ho DH, Jang J, Joe EH, Son I, Seo H, Seol W. Ho DH, et al. Biomed Res Int. 2016;2016:7917128. doi: 10.1155/2016/7917128. Epub 2016 May 25. Biomed Res Int. 2016. PMID: 27314038 Free PMC article.

5

Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity.

Nguyen AP, Moore DJ. Nguyen AP, et al. Adv Neurobiol. 2017;14:71-88. doi: 10.1007/978-3-319-49969-7_4. Adv Neurobiol. 2017. PMID: 28353279 Free PMC article. Review.

6

Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.

Nguyen APT, Tsika E, Kelly K, Levine N, Chen X, West AB, Boularand S, Barneoud P, Moore DJ. Nguyen APT, et al. Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17296-17307. doi: 10.1073/pnas.1922184117. Epub 2020 Jul 6. Proc Natl Acad Sci U S A. 2020. PMID: 32631998 Free PMC article.

7

Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding.

Kalogeropulou AF, Purlyte E, Tonelli F, Lange SM, Wightman M, Prescott AR, Padmanabhan S, Sammler E, Alessi DR. Kalogeropulou AF, et al. Biochem J. 2022 Sep 16;479(17):1759-1783. doi: 10.1042/BCJ20220161. Biochem J. 2022. PMID: 35950872 Free PMC article.

8

Heterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implications.

Rudenko IN, Cookson MR. Rudenko IN, et al. Neurotherapeutics. 2014 Oct;11(4):738-50. doi: 10.1007/s13311-014-0284-z. Neurotherapeutics. 2014. PMID: 24957201 Free PMC article. Review.

9

Clinical features of LRRK2 parkinsonism.

Haugarvoll K, Wszolek ZK. Haugarvoll K, et al. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S205-8. doi: 10.1016/S1353-8020(09)70815-6. Parkinsonism Relat Disord. 2009. PMID: 20082991 Review.

10

Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease.

Gandhi PN, Chen SG, Wilson-Delfosse AL. Gandhi PN, et al. J Neurosci Res. 2009 May 1;87(6):1283-95. doi: 10.1002/jnr.21949. J Neurosci Res. 2009. PMID: 19025767 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

121 results

Results by year